Roche gets EU approval for Herceptin to treat HER2-positive advanced stomach cancer
Friday, January 29, 2010 09:00 IST Basel
Roche announced that the European Commission has approved Herceptin (trastuzumab) in combination with chemotherapy for use in patients with HER2-positive metastatic stomach (gastric) cancer.